Cardiovascular Magnetic Resonance
1. Cardiovascular Magnetic Resonance - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Dedication - p. v 7. Contributors - p. vii 8. Foreword - p. xiii 9. SECTION I. BASIC PRINCIPLES AND TECHNOLOGY - p. S1 10. 1. Physics, Instrumentation, and Basic Sequences - p. 1 11. 2. Cardiovascular Magnetic Resonance Contrast Agents - p. 18 12. 3. Gating, Motion Correction, and Image Acceleration - p. 34 13. 4. Techniques for T1, T2, and Extra-Cellular Volume (ECV) Mapping - p. 46 14. 5. Blood Flow Velocity Assessment - p. 66 15. 6. Myocardial Imaging: Advanced Techniques - p. 79 16. 7. Myocardial Perfusion Imaging—Techniques - p. 100 17. 8. Cardiac Magnetic Resonance Image Artifacts - p. 118 18. SECTION II. EMERGING TECHNOLOGY WITH REQUIREMENTS FOR CLINICAL USE - p. S2 19. 9. Artificial Intelligence: Promises, Pitfalls, and Ethical Considerations - p. 129 20. 10. Mid-Field Cardiovascular Magnetic Resonance Imaging - p. 139 21. 11. Cardiac Magnetic Resonance Spectroscopy - p. 149 22. SECTION III. CLINICAL CMR LABORATORY - p. S3 23. 12. Special Considerations for Cardiovascular Magnetic Resonance: Safety, Electrocardiographic Setup, Monitoring, and Contraindications - p. 165 24. 13. The Core Clinical Cardiovascular Magnetic Resonance Examination - p. 174 25. 14. Scan Reporting and Registries - p. 195 26. 15. Cost-Effectiveness Analysis for Cardiovascular Magnetic Resonance Imaging - p. 203 27. 16. Normal Values in Cardiovascular Magnetic Resonance Imaging - p. 211 28. 17. Left Ventricular Structure and Function - p. 225 29. 18. Right Ventricular Cardiovascular Magnetic Resonance Imaging - p. 233 30. 19. Atrial Structure and Function - p. 243 31. SECTION IV. ISCHEMIC HEART DISEASE - p. S4 32. 20. Stress Cardiovascular Magnetic Resonance: Myocardial Perfusion Imaging - p. 251 33. 21. Technical Foundation and Clinical Utility of Coronary MRI - p. 259 34. 22. Acute Myocardial Infarction - p. 273 35. 23. Myocardial Viability - p. 294 36. 24. Identifying the Etiology: A Systematic Approach to Differentiating Ischemic From Nonischemic Disease - p. 310 37. SECTION V. MYOCARDIAL AND PERICARDIAL DISEASE - p. S5 38. 25. Hypertrophic Cardiomyopathy - p. 327 39. 26. Role of Cardiovascular Magnetic Resonance in Dilated Cardiomyopathy - p. 341 40. 27. Infiltrative Cardiomyopathies - p. 354 41. 28. Cardiac Iron Loading and Cardiovascular Magnetic Resonance - p. 361 42. 29. Arrhythmogenic Cardiomyopathies - p. 376 43. 30. Myocarditis - p. 417 44. 31. Cardio-Oncology - p. 436 45. 32. Cardiac Thrombus - p. 455 46. 33. CMR of Cardiac Masses - p. 466 47. 34. The Pericardium: Anatomy, Function, and Disease - p. 486 48. SECTION VI. VALVULAR DISEASE - p. S6 49. 35. Assessment of Valvular Heart Disease Using Cardiac Magnetic Resonance Imaging - p. 499 50. 36. Cardiac Remodeling and Implications of Valvular Heart Disease - p. 525 51. 37. Pulmonary Vein Angiography and Left Atrial Fibrosis Imaging - p. 540 52. 38. Cardiovascular Magnetic Resonance Angiography: Carotids, Aorta, and Peripheral Vessels - p. 551 53. 39. Thoracic Aortic Disease - p. 572 54. 40. Pulmonary Artery Magnetic Resonance Imaging - p. 585 55. SECTION VII. CONGENITAL HEART DISEASE - p. S7 56. 41. Safety Monitoring and Protocols in Infants and Children - p. 597 57. 42. Pediatric and Congenital Heart Disease - p. 614 58. Appendix A. Cardiac Magnetic Resonance Screening Form: Duke Cardiovascular Magnetic Resonance Center - p. 645 59. Appendix B. Cardiac Magnetic Resonance Pulse Sequence Parameters and Protocols at Duke Cardiovascular Magnetic Resonance Center - p. 647 60. Appendix C. Cardiac Magnetic Resonance Acronyms Used by Various Vendors - p. 649 61. Index - p. 653
Cardiovascular Magnetic Resonance
1. Cardiovascular Magnetic Resonance - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Dedication - p. v 7. Contributors - p. vii 8. Foreword - p. xiii 9. SECTION I. BASIC PRINCIPLES AND TECHNOLOGY - p. S1 10. 1. Physics, Instrumentation, and Basic Sequences - p. 1 11. 2. Cardiovascular Magnetic Resonance Contrast Agents - p. 18 12. 3. Gating, Motion Correction, and Image Acceleration - p. 34 13. 4. Techniques for T1, T2, and Extra-Cellular Volume (ECV) Mapping - p. 46 14. 5. Blood Flow Velocity Assessment - p. 66 15. 6. Myocardial Imaging: Advanced Techniques - p. 79 16. 7. Myocardial Perfusion Imaging—Techniques - p. 100 17. 8. Cardiac Magnetic Resonance Image Artifacts - p. 118 18. SECTION II. EMERGING TECHNOLOGY WITH REQUIREMENTS FOR CLINICAL USE - p. S2 19. 9. Artificial Intelligence: Promises, Pitfalls, and Ethical Considerations - p. 129 20. 10. Mid-Field Cardiovascular Magnetic Resonance Imaging - p. 139 21. 11. Cardiac Magnetic Resonance Spectroscopy - p. 149 22. SECTION III. CLINICAL CMR LABORATORY - p. S3 23. 12. Special Considerations for Cardiovascular Magnetic Resonance: Safety, Electrocardiographic Setup, Monitoring, and Contraindications - p. 165 24. 13. The Core Clinical Cardiovascular Magnetic Resonance Examination - p. 174 25. 14. Scan Reporting and Registries - p. 195 26. 15. Cost-Effectiveness Analysis for Cardiovascular Magnetic Resonance Imaging - p. 203 27. 16. Normal Values in Cardiovascular Magnetic Resonance Imaging - p. 211 28. 17. Left Ventricular Structure and Function - p. 225 29. 18. Right Ventricular Cardiovascular Magnetic Resonance Imaging - p. 233 30. 19. Atrial Structure and Function - p. 243 31. SECTION IV. ISCHEMIC HEART DISEASE - p. S4 32. 20. Stress Cardiovascular Magnetic Resonance: Myocardial Perfusion Imaging - p. 251 33. 21. Technical Foundation and Clinical Utility of Coronary MRI - p. 259 34. 22. Acute Myocardial Infarction - p. 273 35. 23. Myocardial Viability - p. 294 36. 24. Identifying the Etiology: A Systematic Approach to Differentiating Ischemic From Nonischemic Disease - p. 310 37. SECTION V. MYOCARDIAL AND PERICARDIAL DISEASE - p. S5 38. 25. Hypertrophic Cardiomyopathy - p. 327 39. 26. Role of Cardiovascular Magnetic Resonance in Dilated Cardiomyopathy - p. 341 40. 27. Infiltrative Cardiomyopathies - p. 354 41. 28. Cardiac Iron Loading and Cardiovascular Magnetic Resonance - p. 361 42. 29. Arrhythmogenic Cardiomyopathies - p. 376 43. 30. Myocarditis - p. 417 44. 31. Cardio-Oncology - p. 436 45. 32. Cardiac Thrombus - p. 455 46. 33. CMR of Cardiac Masses - p. 466 47. 34. The Pericardium: Anatomy, Function, and Disease - p. 486 48. SECTION VI. VALVULAR DISEASE - p. S6 49. 35. Assessment of Valvular Heart Disease Using Cardiac Magnetic Resonance Imaging - p. 499 50. 36. Cardiac Remodeling and Implications of Valvular Heart Disease - p. 525 51. 37. Pulmonary Vein Angiography and Left Atrial Fibrosis Imaging - p. 540 52. 38. Cardiovascular Magnetic Resonance Angiography: Carotids, Aorta, and Peripheral Vessels - p. 551 53. 39. Thoracic Aortic Disease - p. 572 54. 40. Pulmonary Artery Magnetic Resonance Imaging - p. 585 55. SECTION VII. CONGENITAL HEART DISEASE - p. S7 56. 41. Safety Monitoring and Protocols in Infants and Children - p. 597 57. 42. Pediatric and Congenital Heart Disease - p. 614 58. Appendix A. Cardiac Magnetic Resonance Screening Form: Duke Cardiovascular Magnetic Resonance Center - p. 645 59. Appendix B. Cardiac Magnetic Resonance Pulse Sequence Parameters and Protocols at Duke Cardiovascular Magnetic Resonance Center - p. 647 60. Appendix C. Cardiac Magnetic Resonance Acronyms Used by Various Vendors - p. 649 61. Index - p. 653
